Cargando…

Behavioural alterations are independent of sickness behaviour in chronic experimental Chagas disease

The existence of the nervous form of Chagas disease is a matter of discussion since Carlos Chagas described neurological disorders, learning and behavioural alterations in Trypanosoma cruzi-infected individuals. In most patients, the clinical manifestations of the acute phase, including neurological...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vilar-Pereira, Glaucia, Ruivo, Leonardo Alexandre de Souza, Lannes-Vieira, Joseli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto Oswaldo Cruz, Ministério da Saúde 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708025/ https://www.ncbi.nlm.nih.gov/pubmed/26676323 http://dx.doi.org/10.1590/0074-02760150300

Ejemplares similares

Combination Chemotherapy with Suboptimal Doses of Benznidazole and Pentoxifylline Sustains Partial Reversion of Experimental Chagas' Heart Disease
por: Vilar-Pereira, Glaucia, et al.
Publicado: (2016)

Severity of chronic experimental Chagas' heart disease parallels tumour necrosis factor and nitric oxide levels in the serum: models of mild and severe disease
por: Pereira, Isabela Resende, et al.
Publicado: (2014)

Tumor Necrosis Factor Is a Therapeutic Target for Immunological Unbalance and Cardiac Abnormalities in Chronic Experimental Chagas' Heart Disease
por: Pereira, Isabela Resende, et al.
Publicado: (2014)

Anxiety, depression, and memory loss in Chagas disease: a puzzle far beyond neuroinflammation to be unpicked and solved(*)
por: Lannes-Vieira, Joseli, et al.
Publicado: (2023)

Multi-therapeutic strategy targeting parasite and inflammation-related alterations to improve prognosis of chronic Chagas cardiomyopathy: a hypothesis-based approach(*)
por: Lannes-Vieira, Joseli
Publicado: (2022)

Treatment With Suboptimal Dose of Benznidazole Mitigates Immune Response Molecular Pathways in Mice With Chronic Chagas Cardiomyopathy
por: Farani, Priscila Silva Grijó, et al.
Publicado: (2021)

Memory impairment in chronic experimental Chagas disease: Benznidazole therapy reversed cognitive deficit in association with reduction of parasite load and oxidative stress in the nervous tissue
por: Vilar-Pereira, Glaucia, et al.
Publicado: (2021)

Physical Exercise Promotes a Reduction in Cardiac Fibrosis in the Chronic Indeterminate Form of Experimental Chagas Disease
por: Pedra-Rezende, Yasmin, et al.
Publicado: (2021)

Pentoxifylline Reverses Chronic Experimental Chagasic Cardiomyopathy in Association with Repositioning of Abnormal CD8(+) T-Cell Response
por: Pereira, Isabela Resende, et al.
Publicado: (2015)

Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy
por: Silva Grijó Farani, Priscila, et al.
Publicado: (2023)

Resveratrol Reverses Functional Chagas Heart Disease in Mice
por: Vilar-Pereira, Glaucia, et al.
Publicado: (2016)

Vascular Growth Factor Inhibition with Bevacizumab Improves Cardiac Electrical Alterations and Fibrosis in Experimental Acute Chagas Disease
por: Nisimura, Lindice Mitie, et al.
Publicado: (2023)

Behavioural biology of Chagas disease vectors
por: Lazzari, Claudio Ricardo, et al.
Publicado: (2013)

The Centennial of the Discovery of Chagas Disease: Facing the Current Challenges
por: Lannes-Vieira, Joseli, et al.
Publicado: (2010)

Genetic Ablation and Pharmacological Blockade of Bradykinin B1 Receptor Unveiled a Detrimental Role for the Kinin System in Chagas Disease Cardiomyopathy
por: Oliveira, Ana Carolina, et al.
Publicado: (2023)

TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas’ heart disease
por: Ferreira, Roberto Rodrigues, et al.
Publicado: (2019)

In Chagas disease, transforming growth factor beta neutralization reduces Trypanosoma cruzi infection and improves cardiac performance
por: Ferreira, Roberto Rodrigues, et al.
Publicado: (2022)

Alterations in sick dairy cows’ daily behavioural patterns
por: Dittrich, I., et al.
Publicado: (2019)

A Human Type 5 Adenovirus-Based Trypanosoma cruzi Therapeutic Vaccine Re-programs Immune Response and Reverses Chronic Cardiomyopathy
por: Pereira, Isabela Resende, et al.
Publicado: (2015)

Genetic Polymorphism at CCL5 Is Associated With Protection in Chagas’ Heart Disease: Antagonistic Participation of CCR1(+) and CCR5(+) Cells in Chronic Chagasic Cardiomyopathy
por: Batista, Angelica Martins, et al.
Publicado: (2018)

CCL3/Macrophage Inflammatory Protein-1α Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFNγ-Enriched Inflammatory Milieu in Trypanosoma cruzi-Induced Chronic Cardiomyopathy
por: Gibaldi, Daniel, et al.
Publicado: (2020)

ASP-2/Trans-sialidase chimeric protein induces robust protective immunity in experimental models of Chagas’ disease
por: Castro, Julia T., et al.
Publicado: (2023)

Rules as to Behaviour during Sickness
Publicado: (1916)

Extracellular Vesicles: Potential Role in Remote Signaling and Inflammation in Trypanosoma cruzi-Triggered Disease
por: Dantas-Pereira, Luíza, et al.
Publicado: (2021)

Insights from the use of erythropoietin in experimental Chagas disease
por: de Castro Nobre, Ana Carolina, et al.
Publicado: (2022)

Mapping health behaviour related to Chagas diagnosis in a non-endemic country: Application of Andersen’s Behavioural Model
por: Iglesias-Rus, Laura, et al.
Publicado: (2022)

Integration of miRNA and gene expression profiles suggest a role for miRNAs in the pathobiological processes of acute Trypanosoma cruzi infection
por: Ferreira, Ludmila Rodrigues Pinto, et al.
Publicado: (2017)

Single nucleotide polymorphisms of cytokine-related genes and association with clinical outcome in a Chagas disease case-control study from Brazil
por: Alvarado-Arnez, Lucia Elena, et al.
Publicado: (2018)

“Chagas Express XXI”: A new ArtScience social technology for health and science education—A case study in Brazilian endemic areas of Chagas disease with an active search of chronic cases
por: Araujo-Jorge, Tania C., et al.
Publicado: (2021)

Agrochemicals against Malaria, Sleeping Sickness, Leishmaniasis and Chagas Disease
por: Witschel, Matthias, et al.
Publicado: (2012)

Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
por: Khare, Shilpi, et al.
Publicado: (2016)

Acidification and γ-aminobutyric acid independently alter kairomone-induced behaviour
por: Charpentier, Corie L., et al.
Publicado: (2016)

Bacterial peptidoglycan enhances sickness behaviour induced by bacterial lipopolysaccharide
por: Farzi, Aitak, et al.
Publicado: (2011)

Influence of Angiotensin-converting Enzyme Insertion/Deletion Gene Polymorphism in Progression of Chagas Heart Disease
por: Alves, Silvia Marinho Martins, et al.
Publicado: (2020)

CD8(+) T-Cells Expressing Interferon Gamma or Perforin Play Antagonistic Roles in Heart Injury in Experimental Trypanosoma Cruzi-Elicited Cardiomyopathy
por: Silverio, Jaline Coutinho, et al.
Publicado: (2012)

Tolerogenic Dendritic Cells Reduce Cardiac Inflammation and Fibrosis in Chronic Chagas Disease
por: Santos, Emanuelle de Souza, et al.
Publicado: (2020)

Brainstem ADCYAP1(+) neurons control multiple aspects of sickness behaviour
por: Ilanges, Anoj, et al.
Publicado: (2022)

Putative involvement of sirtuin modulators in LPS-induced sickness behaviour in mice
por: Kinra, Manas, et al.
Publicado: (2022)

Phytochemistry, Pharmacology and Molecular Mechanisms of Herbal Bioactive Compounds for Sickness Behaviour
por: Alotaibi, Ghallab Hamoud Sinhat, et al.
Publicado: (2022)

Trypanosoma cruzi activates mouse cardiac fibroblasts in vitro leading to fibroblast-myofibroblast transition and increase in expression of extracellular matrix proteins
por: Coelho, Laura Lacerda, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_icon0roe9plg4rgm6hgupcmnp8